))
Colchi(seen) to Reduce Cardiovascular Risk in Established ASCVD
Manage episode 389199255 series 2908322
Indhold leveret af Mayo Clinic. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Mayo Clinic eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Maggie Ruschmeyer, PharmD reviews the evidence in colchicine for secondary prevention of ASCVD.
For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.
You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
101 episoder
Del
